title: Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness.
authors.affiliation: Department of Medical Oncology, National Cancer Institute, Aviano (PN) Italy. rainoneaniello@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Lleshi
authors.forename: A
authors.initials: A
authors.lastname: Rainone